Edition:
United Kingdom

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

624.70INR
20 Aug 2018
Change (% chg)

-- (--)
Prev Close
Rs624.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
457,712
52-wk High
Rs633.25
52-wk Low
Rs434.80

Latest Key Developments (Source: Significant Developments)

Sun Pharma Announces U.S. FDA Approval Of Cequa To Treat Dry Eye Disease
Thursday, 16 Aug 2018 

Aug 16 (Reuters) - Sun Pharmaceutical Industries Ltd ::SUN PHARMA ANNOUNCES U.S. FDA APPROVAL OF CEQUA™ TO TREAT DRY EYE DISEASE.  Full Article

Sun Pharmaceutical Industries Says Sales In U.S. Were $380 Mln In Q1, Up 8 Pct
Tuesday, 14 Aug 2018 

Aug 14 (Reuters) - Sun Pharmaceutical Industries Ltd ::SAYS SALES IN THE U.S WERE US$ 380 MILLION FOR THE QUARTER, A GROWTH OF 8% OVER SAME PERIOD LAST YEAR.SUN PHARMACEUTICAL INDUSTRIES - CREATING PIPELINE OF SPECIALTY PRODUCTS; DURING THE YEAR LAUNCHES WILL RESULT IN SIGNIFICANT UPFRONT INVESTMENTS.  Full Article

India's Sun Pharmaceutical Industries Posts June Qtr Consol Profit
Tuesday, 14 Aug 2018 

Aug 14 (Reuters) - Sun Pharmaceutical Industries Ltd ::JUNE QUARTER CONSOL NET PROFIT 9.83 BILLION RUPEES VERSUS LOSS OF 4.25 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR JUNE QUARTER CONSOL PROFIT WAS 8.97 BILLION RUPEES.JUNE QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 72.24 BILLION RUPEES VERSUS 62.09 BILLION RUPEES LAST YEAR.  Full Article

Sun Pharmaceutical Industries Launches Novel Drug Kapspargo Sprinkle In USA
Monday, 6 Aug 2018 

Aug 6 (Reuters) - Sun Pharmaceutical Industries Ltd ::SAYS CO LAUNCHES NOVEL DRUG KAPSPARGO SPRINKLE IN USA.  Full Article

India's Sun Pharmaceutical Industries Gets U.S. FDA Nod For INFUGEM Injection
Wednesday, 18 Jul 2018 

July 18 (Reuters) - Sun Pharmaceutical Industries Ltd ::GETS U.S. FDA APPROVAL FOR INFUGEM INJECTION.  Full Article

Beijing Science Sun Pharmaceutical sees FY 2018 H1 net profit up 5 pct to 35 pct
Friday, 13 Jul 2018 

July 13(Reuters) - Beijing Science Sun Pharmaceutical Co Ltd <300485.SZ> : :Sees FY 2018 H1 net profit to increase by 5 percent to 35 percent, or to be 110.6 million yuan to 142.2 million yuan.Says FY 2017 H1 net profit was 105.3 million yuan.The reasons for the forecast are improved marketing promotion and enhanced internal management .  Full Article

Sun Pharmaceutical Unit Files Lawsuit Against Biofrontera For Patent Infringement
Wednesday, 11 Jul 2018 

July 11 (Reuters) - Biofrontera AG ::SUN PHARMACEUTICAL INDUSTRIES LTD - CO'S UNIT, DUSA PHARMACEUTICALS FILES LAWSUIT AGAINST BIOFRONTERA FOR PATENT INFRINGEMENT.SUN PHARMACEUTICAL INDUSTRIES - LAWSUIT ALLEGES PATENT INFRINGEMENT OF DUSA'S PATENTS, US 9,723,991 AND US 8,216,289.  Full Article

US FDA Says Issues Voluntary Action Indicated Status To India's Sun Pharma On Halol Drug Plant
Friday, 8 Jun 2018 

June 8 (Reuters) - Sun Pharmaceutical Industries Ltd ::US FDA SAYS ISSUES VOLUNTARY ACTION INDICATED STATUS TO INDIA'S SUN PHARMA ON HALOL DRUG PLANT.  Full Article

Sun Pharmaceutical Industries' Units Gets Approval For Yonsa
Wednesday, 23 May 2018 

May 23 (Reuters) - Sun Pharmaceutical Industries Ltd ::U.S.FDA APPROVAL OF YONSA.ONE OF CO'S WHOLLY OWNED UNITS GOT APPROVAL FOR YONSA.CHURCHILL PHARMACEUTICALS, ELIGIBLE TO GET UPFRONT AND SALES-LINKED MILESTONE PAYMENT AND ROYALTIES ON SALES FROM CO.  Full Article

Perrigo Confirms First To File Patent Challenge For Generic Ultravate Lotion
Monday, 14 May 2018 

May 14 (Reuters) - Perrigo Company PLC ::PERRIGO CONFIRMS FIRST TO FILE PATENT CHALLENGE FOR GENERIC VERSION OF ULTRAVATE LOTION, 0.05%.PERRIGO COMPANY PLC - SUN PHARMACEUTICAL INDUSTRIES & MICAL PHARMACEUTICALS INITIATED PATENT LITIGATIONS ON MAY 9 & 10, 2018.PERRIGO COMPANY PLC - LITIGATIONS REGARDING PARAGRAPH IV ABBREVIATED NDA FOR HALOBETASOL PROPIONATE LOTION, 0.05%.  Full Article

UPDATE 1-India's Sun Pharma Q1 profit beats estimates as U.S. sales climb

* Stock top gainer on NSE index (Adds details on U.S. and India sales, share movement)